Porton Reports Strong Half-Year Results
Porton Reports Strong Half-Year Results Read More »
The Center for Pharma Crystallization (CfPC) at J-Star Research, Inc., a US based subsidiary of Porton Pharma Solutions, is pleased to announce the program of the 2nd annual Pharmaceutical Crystallization Summit, to be held on October 14 and 15, 2021, jointly with our partners XtalPi, BlazeMetrics, and Technobis. The 2-day event includes 4 sessions, with
CfPC Announces Program Of 2021 Pharmaceutical Crystallization Summit (Reproduced) Read More »
South Plainfield, NJ., March 12, 2020 — J-Star Research, Inc, the leading Contract Research Organization focused on Small Molecule Process Research and Crystallization R&D, is proud to announce the launch of its newly redesigned website at https://www.jstar-research.com. The new site features a streamlined, modern design, improved functionality, and easy access to essential information to help
J-Star Research, Inc launches new website Read More »
March 10, 2020, Chongqing • China–XtalPi Inc.(hereafter referred to as XtalPi), an algorithm-driven AI pharmaceutical technology company, announced the signing of a strategic cooperation agreement today. The two parties aim to carry out all-round strategic cooperation on the basis of sincere cooperation and mutual benefit. As a high standard CDMO, Porton has outstanding integrated experiences in
Porton and Xtalpi Announced Strategic Cooperation Read More »
CRANBURY, N.J., Wednesday April 5th, 2017—Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary of Porton, has closed the previously announced transcation with the shareholders of J-STAR Research, Inc. (“J-STAR”), a contract chemistry organization
Porton Completes Acquisition of J-STAR Research Read More »
CRANBURY, N.J., Wednesday April 5th, 2017—Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary of Porton, has closed the previously announced transcation with the shareholders of Porton USA, Inc. (“J-STAR”), a contract chemistry organization
Porton Completes Acquisition of Porton USA Read More »
CRANBURY, N.J., Jan. 27, 2017 /PRNewswire/ — Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary of Porton, has entered into a stock purchase agreement with the shareholders of J-STAR Research, Inc. (“J-STAR”), a contract chemistry organization based in South
CRANBURY, N.J., Jan. 27, 2017 /PRNewswire/ — Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary of Porton, has entered into a stock purchase agreement with the shareholders of Porton USA, Inc. (“J-STAR”), a contract chemistry organization based in South
Porton USA to Acquire Porton USA to Expand Its Research and Development Capabilities Read More »